Abstract:Disordered proteins and domains often assemble into condensates with polyanionic nucleic acids, primarily via charge complementarity, regulating numerous cellular functions. However, the assembly mechanisms associated with the other abundant and ubiquitous, anionic, stress-response regulating polymer, polyphosphate (polyP), is less understood. Here, we employ the intrinsically disordered DNA binding domain (DBD) of cytidine repressor (CytR) from E.coli to study the nature of assembly processes and their maturation with polyP and DNA. Wild-type CytR forms metastable liquid-like condensates with polyP and DNA, while undergoing liquid-to-solid transition in the former and solubilizing in the latter. On mutationally engineering the ensemble to exhibit more or less structure and dimensions than the WT, the assembly process with polyP is directed to either condensates with partial time-dependent solubilization or spontaneous aggregation, respectively. The timescales of structural changes in the condensates formed by the folded mutant with polyP span tens of minutes, indicative of slow dynamics and highlights the tussle between folding driven by intra-molecular interactions and assembly mediated by inter-molecular interactions. On the other hand, the CytR variants form only liquid-like but metastable droplets with DNA which solubilize within a few hours. Polyphosphate induces large secondary-structure changes with two of the mutants adopting polyproline II-like structures within droplets, while DNA has only minimal structural effects. Our findings reveal how polyphosphate is able to more efficiently discern conformational heterogeneity in the starting protein ensemble, its structure, and compactness, with broad implications in assembly mechanisms involving polyP and stress response in bacterial systems.

Back on the chain gang: polyphosphate modification of proteins

Polyphosphate attachment to lysine repeats is a non-covalent protein modification

The promises of lysine polyphosphorylation as a regulatory modification in mammals are tempered by conceptual and technical challenges

Investigation of Protein Post-Translational Modifications with Site-Specifically Incorporated Non-Canonical Amino Acids

Inorganic polyphosphate: from basic research to diagnostic and therapeutic opportunities in ALS/FTD

An Inorganic Biopolymer Polyphosphate Controls Positively Charged Protein Phase Transitions.

How phosphorylation by PINK1 remodels the ubiquitin system, a perspective from structure and dynamics.

Positively-charged Semi-Tunnel is a Structural and Surface Characteristic of Polyphosphate-Binding Proteins: an In-Silico Study.

Protein PEPylation: A New Paradigm of Protein-Polymer Conjugation.

Inorganic polyphosphates: biologically active biopolymers for biomedical applications.

[Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1]

Poly(ADP-ribose): the Structure and the Synthesis

Poly‐ADP‐ribosylation dynamics, signaling, and analysis

Inorganic polyphosphate interacts with ribosomes and promotes translation fidelity in vitro and in vivo

Unraveling the battle for lysine: A review of the competition among post-translational modifications

Physiological Polyphosphate: A New Molecular Paradigm in Biomedical and Biocomputational Applications for Human Therapy

Inorganic Polyphosphate: Coacervate Formation and Functional Significance in Nanomedical Applications

Inorganic polyphosphate and ion transport across biological membranes

Post-translational modification control of RNA-binding protein hnRNPK function

Polyphosphate Discriminates Protein Conformational Ensembles More Efficiently than DNA Promoting Diverse Assembly and Maturation Behaviors

Proteome-Wide Identification of poly(ADP-ribose) Binding Proteins